Revisión bibliográfica sobre eficacia y seguridad de la luz ultravioleta y ozono para la desinfección de superficies

Informes de Evaluación de Tecnologías Sanitarias AETS-ISCIIIObjetivos El objetivo de esta revisión bibliográfica es analizar la información disponible sobre la eficacia y seguridad de los dispositivos de luz ultravioleta (UV) y ozono en la desinfección de virus, especialmente en la desinfección del SARS-CoV-2. Metodología Se ha realizado una revisión sistemática de la información científica recogida en las principales bases de datos biomédicas, PubMed, EMBASE y Cochrane Library, así como en las bases de datos WoS y CRD. También se realizó una búsqueda en las bases de datos de las principales agencias de evaluación de tecnologías sanitarias. Resultados La búsqueda bibliográfica ha permitido incluir 15 estudios sobre la eficacia de la luz ultravioleta y ozono en la desinfección de virus. Ninguno de estos estudios analiza la eficacia de la desinfección en el SARS-CoV-2. Para analizar la eficacia de la radiación UV se han incluido 8 estudios primarios y un informe de evaluación de tecnologías sanitarias. Solo un estudio evaluaba la eficacia de la radiación en el ámbito hospitalario. Este estudio realizó un análisis de la eficacia de la radiación UV en la desinfección de habitaciones en un hospital pediátrico concluyendo que este tipo de dispositivo puede reducir la incidencia de infecciones en las vías respiratorias altas en niños. Dos de los estudios incluidos analizaron la eficacia de la radiación UV para la desinfección y reutilización de mascarillas. Los resultados de estos estudios indicaban que la radiación UV disminuía la carga vírica de las mascarillas, pero esta reducción podría no ser suficiente para lograr la desinfección. Por otro lado, la reducción de patógenos depende del tipo de patógeno y del diseño y material de las mascarillas. Por último, se han incluido cinco estudios que estudian a escala de laboratorio la eficacia de la radiación UV en la desinfección de distintos patógenos, entre los que se incluyen SARS-CoV y MERS-CoV. En todos estos estudios se concluye que la UV sería eficaz en la reducción de patógenos, aunque sería más efectiva para la desinfección de bacterias que para virus. de Evaluación de Tecnologías Sanitarias AETS-ISCIIIS

Detection of a large Be circumstellar disk during X-ray quiescence of XTE J1946+274

We present a multiwavelength study of the Be/X-ray binary system XTE J1946+274 with the main goal of better characterizing its behavior during X-ray quiescence. We aim to shed light on the mechanism which triggers the X-ray activity for this source. XTE J1946+274 was observed by Chandra-ACIS during quiescence in 2013 March 12. In addition, this source has been monitored from the ground-based astronomical observatories of El Teide (Tenerife, Spain), Roque de los Muchachos (La Palma, Spain) and Sierra Nevada (Granada, Spain) since 2011 September, and from the TUBITAK National Observatory (Antalya, Turkey) since 2005 April. We have performed spectral and photometric temporal analyses in order to investigate the quiescent state and transient behavior of this binary system. In 2006, a long mass ejection event took place from the Be star, lasting for about seven years. We also found that a large Be circumstellar disk was present during quiescence, although major X-ray activity was not observed. We made an attempt to explain this scenario by assuming the permanently presence of a tilted and warped Be circumstellar disk. The 0.3-10 keV X-ray spectrum during quiescence was well fitted with either an absorbed blackbody or absorbed power-law models. The main parameters obtained for these models were kT=1.43+/-0.17 and Gamma=0.9+/-0.4 (with N_H~2-7E+22 cm-2). The 0.3-10 keV flux of the source was ~0.8E-12 erg-1 cm-2 s-1. Pulsations were found with P_pulse=15.757(1) s (MJD 56363.115) and an rms pulse fraction of 32.1(3)%. The observed X-ray luminosity during quiescent periods may be explained by the neutron star being in supersonic propeller regimen.Comment: 9 pages, 7 figures, accepte

UV-stable paper coated with APTES-modified P25 TiO2 nanoparticles

In order to inhibit the photocatalytic degradation of organic material supports induced by small titania (TiO2) nanoparticles, highly photocatalytically active, commercially available P25-TiO2 nanoparticles were first modified with a thin layer of (3-aminopropyl) triethoxysilane (APTES), which were then deposited and fixed onto the surface of paper samples via a simple, dip-coating process in water at room temperature. The resultant APTES-modified P25 TiO2 nanoparticle-coated paper samples exhibit much greater stability to UV-illumination than uncoated blank reference paper. Very little, or no, photo-degradation in terms of brightness and whiteness, respectively, of the P25-TiO2-nanoparticle-treated paper is observed. There are many other potential applications for this Green Chemistry approach to protect cellulosic fibres from UV-bleaching in sunlight and to protect their whiteness and maintain their brightness

Prolonged survival of patients with angioimmunoblastic T-cell lymphoma after high-dose chemotherapy and autologous stem cell transplantation: the GELTAMO experience

Abstract OBJECTIVES: Angioimmunoblastic T-cell lymphoma (AIL) is a rare lymphoma with a poor prognosis and no standard treatment. Here, we report our experiences with 19 patients treated with high-dose chemotherapy and autologous stem cell transplantation (HDC/ASCT) within the GELTAMO co-operative group between 1992 and 2004. METHODS: The median age at transplantation was 46 yr. Fifteen patients underwent the procedure as front-line therapy and four patients as salvage therapy. Most patients received peripheral stem cells (90%) coupled with BEAM or BEAC as conditioning regimen (79%). RESULTS: A 79% of patients achieved complete response, 5% partial response and 16% failed the procedure. After a median follow-up of 25 months, eight patients died (seven of progressive disease and secondary neoplasia), while actuarial overall survival and progression-free survival at 3 yr was 60% and 55%. Prognostic factors associated with a poor outcome included bone marrow involvement, transplantation in refractory disease state, attributing more than one factor of the age-adjusted-International Prognostic Index, Pretransplant peripheral T-cell lymphoma (PTCL) Score or Prognostic Index for PTCL. CONCLUSIONS: More than half of the patients with AIL that display unfavourable prognostic factors at diagnosis or relapse would be expected to be alive and disease-free after 3 yr when treated with HDC/ASCT. Patients who are transplanted in a refractory disease state do not benefit from this procedure

Follicular lymphoma international prognostic index.

The prognosis of follicular lymphomas (FL) is heterogeneous and numerous treatments may be proposed. A validated prognostic index (PI) would help in evaluating and choosing these treatments. Characteristics at diagnosis were collected from 4167 patients with FL diagnosed between 1985 and 1992. Univariate and multivariate analyses were used to propose a PI. This index was then tested on 919 patients. Five adverse prognostic factors were selected: age (> 60 years vs or = 120 g/L), number of nodal areas (> 4 vs or = 3 adverse factors, 27% of patients, HR = 4.3). This Follicular Lymphoma International Prognostic Index (FLIPI) appeared more discriminant than the International Prognostic Index proposed for aggressive non-Hodgkin lymphomas. Results were very similar in the confirmation group. The FLIPI may be used for improving treatment choices, comparing clinical trials, and designing studies to evaluate new treatments

Changes in the requirement for early surgery in inflammatory bowel disease in the era of biological agents

This is the peer reviewed version of the following article: Changes in the requirement for early surgery in inflammatory bowel disease in the era of biological agents. Journal of Gastroenterology and Hepatology (2020): 29 April, which has been published in final form at https://doi.org/10.1111/jgh.15084. This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for Use of Self-Archived VersionsBiological therapies may be changing the natural history of inflammatory bowel diseases, reducing the need for surgical intervention. We aimed to assess whether the availability of anti‐TNF agents impacts the need for early surgery in Crohn's disease (CD) and ulcerative colitis (UC). Methods Retrospective, cohort study of patients diagnosed within a 6‐year period before and after the licensing of anti‐TNFs (1990‐1995 and 2007‐2012 for CD; 1995‐2000 and 2007‐2012 for UC) were identified in the ENEIDA Registry. Surgery‐free survival curves were compared between cohorts. Results A total of 7,370 CD patients (2,022 in Cohort 1 and 5,348 in Cohort 2) and 8,069 UC patients (2,938 in Cohort 1 and 5,131 in Cohort 2) were included. Immunosuppressants were used significantly earlier and more frequently in both CD and UC post‐biological cohorts. The cumulative probability of surgery was lower in CD following anti‐TNF approval (16% and 11%, 22% and 16%, and 29% and 19%, at 1, 3 and 5 years, respectively p<0.0001), though not in UC (3% and 2%, 4% and 4%, and 6% and 5% at 1, 3 and 5 years, respectively; p=0.2). Ileal involvement, older age at diagnosis and active smoking in CD, and extensive disease in UC, were independent risk factors for surgery, whereas high‐volume IBD centres (in both CD and UC) and immunosuppressant use (in CD) were protective factors. Conclusions Anti‐TNF availability was associated with a reduction in early surgery for CD (driven mainly by earlier and more widespread immunosuppressant use) but not in U